Effects of sufentanil and naltrexone on adrenal vein catecholamines and neuropeptides during splanchnic nerve stimulation in cats.
Gaumann
D M
DM
Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905.
Yaksh
T L
TL
Tyce
G M
GM
D000311:Adrenal Glands / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D004558:Electric Stimulation; D005283:Fentanyl / Q000031:analogs & derivatives* / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D009271:Naltrexone / Q000494:pharmacology*; D009479:Neuropeptides / Q000378:metabolism*; D013153:Splanchnic Nerves / Q000502:physiology*; D017409:Sufentanil; D014680:Veins / Q000378:metabolism
D000700:Analgesics; D002395:Catecholamines; D009479:Neuropeptides; D009271:Naltrexone; D017409:Sufentanil; D005283:Fentanyl